It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Muconic acid is a bioprivileged molecule that can be converted into direct replacement chemicals for incumbent petrochemicals and performance-advantaged bioproducts. In this study, Pseudomonas putida KT2440 is engineered to convert glucose and xylose, the primary carbohydrates in lignocellulosic hydrolysates, to muconic acid using a model-guided strategy to maximize the theoretical yield. Using adaptive laboratory evolution (ALE) and metabolic engineering in a strain engineered to express the D-xylose isomerase pathway, we demonstrate that mutations in the heterologous D-xylose:H+ symporter (XylE), increased expression of a major facilitator superfamily transporter (PP_2569), and overexpression of aroB encoding the native 3-dehydroquinate synthase, enable efficient muconic acid production from glucose and xylose simultaneously. Using the rationally engineered strain, we produce 33.7 g L−1 muconate at 0.18 g L−1 h−1 and a 46% molar yield (92% of the maximum theoretical yield). This engineering strategy is promising for the production of other shikimate pathway-derived compounds from lignocellulosic sugars.
Muconic acid is a platform chemical with wide industrial applicability. Here, the authors report efficient muconate production from glucose and xylose by engineered Pseudomonas putida strain using adaptive laboratory evolution, metabolic modeling, and rational strain engineering strategies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Peabody, George L. 2 ; Salvachúa, Davinia 1 ; Kim, Young-Mo 3
; Kneucker, Colin M. 1 ; Calvey, Christopher H. 4
; Monninger, Michela A. 1 ; Munoz, Nathalie Munoz 3
; Poirier, Brenton C. 5 ; Ramirez, Kelsey J. 1
; St. John, Peter C. 1
; Woodworth, Sean P. 1
; Magnuson, Jon K. 3
; Burnum-Johnson, Kristin E. 5
; Guss, Adam M. 6
; Johnson, Christopher W. 1
; Beckham, Gregg T. 1
1 Renewable Resources and Enabling Sciences Center, National Renewable Energy Laboratory, Golden, USA (GRID:grid.419357.d) (ISNI:0000 0001 2199 3636); Agile BioFoundry, Emeryville, USA (GRID:grid.419357.d)
2 Agile BioFoundry, Emeryville, USA (GRID:grid.419357.d); Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, USA (GRID:grid.135519.a) (ISNI:0000 0004 0446 2659)
3 Agile BioFoundry, Emeryville, USA (GRID:grid.419357.d); Pacific Northwest National Laboratory, Richland, USA (GRID:grid.451303.0) (ISNI:0000 0001 2218 3491)
4 Renewable Resources and Enabling Sciences Center, National Renewable Energy Laboratory, Golden, USA (GRID:grid.419357.d) (ISNI:0000 0001 2199 3636)
5 Agile BioFoundry, Emeryville, USA (GRID:grid.451303.0); Pacific Northwest National Laboratory, Richland, USA (GRID:grid.451303.0) (ISNI:0000 0001 2218 3491)
6 Agile BioFoundry, Emeryville, USA (GRID:grid.451303.0); Biosciences Division, Oak Ridge National Laboratory, Oak Ridge, USA (GRID:grid.135519.a) (ISNI:0000 0004 0446 2659)




